Ask the whole HKEX filing library.Every answer cites the page.

Or ask from Claude, Codex or another assistant: connect this library也可以在 Claude、Codex 等 AI 助手里直接提问:接入这个先例库

Start here

AI Research

Pro

Ask in plain words; an agent finds comparable issuers, searches the filings and their matters, reads the relevant sections and answers with every point cited.用日常语言提问,AI 会找出可比发行人,检索文件及其事项,阅读相关章节,并给出每一点都注明出处的回答。

Asking about one industry? Start with the kind of issuer: what it sells, to whom, where it sits in its industry.问某个行业的写法时,先说明是什么样的发行人:卖什么、卖给谁、在行业中处于什么位置。

Filings

Public

Every Application Proof, PHIP and prospectus, newest first — with who the company is, who the sponsors are, and each applicant's filings from first proof to prospectus. Filter by company, stage, industry and date; and screen companies by their key facts.每一份 Application Proof、PHIP 和 prospectus,最新在前,并注明公司简介、保荐人,以及每家申请人从首次递表到 prospectus 的全部文件。可按公司、阶段、行业和日期筛选;并可按关键数据筛选公司。

The last 30 days need no account; the whole library needs a free one. Company names open the filing on HKEXnews.过去 30 天的文件无需注册即可查看;完整资料库需免费账户。点击公司名即可在 HKEXnews 打开文件。

Search

Free account

Find how others disclosed it: Boolean for the exact words, Semantic (Pro) for the same idea in other words. Filter by section, document, listing, industry and date; see results by passage, by company, or as a trend over time.看看其他发行人是怎么披露的:Boolean 查精确措辞,Semantic(Pro)查措辞不同、意思相同的段落。可按章节、文件类型、上市板块、行业和日期筛选;结果可按段落、按公司或按时间趋势查看。

Try试试 "social insurance" NEAR/20 shortfall

Matters

Preview free · Pro

Every new filing is read for what it discloses — non-compliance, customer concentration, overlapping customers and suppliers, distributors, losses, net current liabilities, special regimes — sorted by kind, each with how the filing explains it and its own sentences; and a key-facts card for each company that you can screen by the numbers.每份新文件都会被逐一识别其披露的事项——不合规、客户集中、客户与供应商重叠、经销模式、亏损、流动负债净额、特定上市制度等——按类型归类,并附招股书的解释和原文;每家公司另有一张关键数据卡,可按数字筛选。

Try: overlapping customers and suppliers, and how each company explained them.试试:客户与供应商重叠的先例,以及各家公司如何解释。

Comparables

Preview free · Pro

Describe your issuer, or name the companies, and set them side by side: the track record and margins, operating data, the matters each discloses, and their risk factors aligned by kind of risk, with how many of the industry's filings still carry each since the SFC's January 2026 circular.描述你的发行人或直接添加公司,即可并排对照:往绩财务与利润率、运营数据、各公司披露的事项,以及按风险类型对齐的风险因素,并标出 2026 年 1 月证监会通函后同行业文件仍保留各类风险的比例。

Try the example set on the page, then describe your own issuer.可先看页面上的示例,再描述你自己的发行人。

Comment Letter

Preview free · Pro+

What changed from each Application Proof to its PHIP, the roll-forward left out: disclosure added or expanded, claims toned down, text removed — by topic across companies, by industry, or one company chapter by chapter, each with a word-level redline.每份 Application Proof 到其 PHIP 改了什么(剔除日期和数字的例行更新):新增或扩充的披露、降调的措辞、删除的内容——可按主题跨公司查看,可按行业查看,也可逐章查看单家公司,每条附逐词对照。

Try By topic: what recent PHIPs added on customer concentration.试试按主题:近期 PHIP 在客户集中度上补充了什么。

Latest on HKEXnews
All filings →
Thu5 Nov 2026
Prospectus06935.HK

Designs and manufactures commercial satellites, including AI application and AI computing satellites, and provides satellite-based AI solutions such as space intelligence services to customers in China.设计及制造商业卫星(包括人工智能应用卫星和人工智能计算卫星),并面向中国客户提供基于卫星的人工智能解决方案,例如太空智能服务。

Aerospace & Low-altitudeAI & SoftwareSponsorGTJACounselClifford Chance
Fri30 Oct 2026
Prospectus00054.HK

Develops small-molecule drugs for autoimmune diseases and oncology, with one NMPA-approved drug (Mufemilast) and five clinical-stage candidates; markets drugs in China and holds patents in China, the US and other jurisdictions.开发用于自身免疫性疾病和肿瘤的小分子药物,拥有一款获国家药监局批准的药物(Mufemilast)及五款临床阶段候选药物;在中国销售药物,并在中国、美国及其他司法辖区持有专利。

Biotech & PharmaSponsorSDICCounselKing & Wood MallesonsCh. 18A
Prospectus02065.HK

Develops intelligent mobile robotics solutions, including inertial navigation, single-modal and multi-modal robotic solutions, built on its proprietary Amicro platform combining robotics algorithms, SoCs, sensors, motion control modules, SDKs and toolchains for diverse usage scenarios.开发智能移动机器人解决方案,包括惯性导航、单模态及多模态机器人解决方案,该等解决方案基于其专有的Amicro平台构建,该平台集成了机器人算法、SoC、传感器、运动控制模块、SDK及工具链,适用于多种应用场景。

Robotics & AutomationSponsorsCSCI · GTJACounselClifford ChanceCh. 18C
Prospectus02206.HK

Produces and sells TCM decoction-ready products, traditional herbal preparations, wellness products and health management services to hospitals, medical trading companies, pharmacies, pharmaceutical companies and retail consumers across most Chinese provinces, Hong Kong, Taiwan and overseas markets. Ranked second in China with 0.4% market share in 2025.生产并销售中药煎煮即用产品、传统草药制剂、养生产品及健康管理服务,客户涵盖医院、医药贸易公司、药房、制药公司及零售消费者,遍及中国大部分省份、香港、台湾及海外市场。2025年在中国市场以0.4%的市场份额排名第二。

Biotech & PharmaSponsorsGF Securities · ABCICounselKirkland & Ellis
Prospectus02681.HK

Develops and sells memory products, including embedded storage, SSDs, DRAM, mobile storage and memory ICs, with wafer fabrication and packaging outsourced to third parties, serving smartphone, PC, server, data-center and automotive customers globally. Ranked 12th in the global memory market with 0.6% revenue share in 2025, per Frost & Sullivan.开发并销售存储产品,包括嵌入式存储、固态硬盘(SSD)、DRAM、移动存储及存储IC,晶圆制造及封装外包予第三方,服务全球智能手机、个人电脑、服务器、数据中心及汽车客户。据弗若斯特沙利文,于2025年按收入计在全球存储市场排名第十二,市场份额为0.6%。

SemiconductorsSponsorCSCICounselPaul Hastings
+ 3 more that day
Thu29 Oct 2026
PHIP

Designs and manufactures commercial satellites, including AI application and AI computing satellites, and provides satellite-based AI solutions such as space intelligence services to customers in China.设计及制造商业卫星(包括人工智能应用卫星和人工智能计算卫星),并面向中国客户提供基于卫星的人工智能解决方案,例如太空智能服务。

Aerospace & Low-altitudeAI & SoftwareSponsorGTJACounselClifford Chance

Tell us